Clinical trial evidence shows that people who have ponesimod have fewer relapses than people who have teriflunomide., according to NICE final draft guidance.
According to NICE draft guidance, short-term clinical evidence shows that cenobamate reduces the number of seizures. It also increases how many people stop having any seizures.
In draft guidance published today, NICE has recommended cenobamate (also called Ontozry, and made by Arvelle Therapeutics) as a treatment option for epilepsy.
This webinar, featuring an expert panel of speakers, aims to help healthcare professionals to understand what spinal muscular atrophy (SMA) is, how it presents, how to treat it, and why early detection, diagnosis and treatment are essential to children's outcomes.
Ozanimod's effect on the progression of disability is unclear and cost-effectiveness estimates are higher than what NICE normally considers an acceptable use of NHS resources, according to final guidance.
We and selected partners, use cookies or similar technologies as specified in the cookie policy and privacy policy.
You can consent to the use of such technologies by closing this notice.
Cookie Control
Customise your preferences for any tracking technology
The following allows you to customize your consent preferences for any tracking technology used
to help us achieve the features and activities described below. To learn more about how these trackers help us
and how they work, refer to the cookie policy. You may review and change your preferences at any time.
These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.
These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.
Please sign in or register for FREE
Sign in to OnMedica
Membership worth £180/year - free for UK physicians
Join OnMedica today and benefit from:
Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
High-quality, evidence-based content developed by expert editors and clinicians
Articles, quizzes, videos, visual summaries and more
Regulatory alerts and round-up of medical journals
New content added daily, so you know you’re always up to date
See what other members have to say:
"Very useful, I have filled many gaps and gained practical knowledge."
"I feel now more confident in diagnosing the presented conditions. Really it is one of the best learning activities I have completed recently."